Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ferguson

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The FEBS Journal|April 28, 2006
A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonistBrian E Kane, Marcelo J Nieto, Christopher R McCurdy, et al.
Journal of Medicinal Chemistry|October 31, 2008
Quantitative three dimensional structure linear interaction energy model of 5'-O-[N-(salicyl)sulfamoyl]adenosine and the aryl acid adenylating enzyme MbtANicholas P Labello, Eric M Bennett, David M Ferguson, et al.
Progress in Medicinal Chemistry|January 9, 2003
Molecular modeling of opioid receptor-ligand complexesIain McFadyen, Thomas Metzger, Govindan Subramanian, et al.
The Journal of Sexual Medicine|February 2, 2010
Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitorJames W Shaw, Gregory Reardon, David W Sandor, et al.
Bioorganic & Medicinal Chemistry|November 6, 2007
Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptorBrian E Kane, Marianne K O Grant, Esam E El-Fakahany, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8Peter Larson, Tamara A Kucaba, Zhengming Xiong, et al.
Journal of Medicinal Chemistry|March 17, 2006
Identification of compounds with anti-West Nile Virus activityJohn R Goodell, Francesc Puig-Basagoiti, Brett M Forshey, et al.
Nanoscale|November 8, 2018
Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapyHyunjoon Kim, Drishti Sehgal, Tamara A Kucaba, et al.
ACS Medicinal Chemistry Letters|July 28, 2012
Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine InductionCe Shi, Zhengming Xiong, Padmaja Chittepu, et al.
Bioorganic & Medicinal Chemistry|February 5, 2010
Synthesis and cancer cell cytotoxicity of substituted xanthenesRajan Giri, John R Goodell, Chenguo Xing, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The FEBS Journal|April 28, 2006
A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonistBrian E Kane, Marcelo J Nieto, Christopher R McCurdy, et al.
Journal of Medicinal Chemistry|October 31, 2008
Quantitative three dimensional structure linear interaction energy model of 5'-O-[N-(salicyl)sulfamoyl]adenosine and the aryl acid adenylating enzyme MbtANicholas P Labello, Eric M Bennett, David M Ferguson, et al.
Progress in Medicinal Chemistry|January 9, 2003
Molecular modeling of opioid receptor-ligand complexesIain McFadyen, Thomas Metzger, Govindan Subramanian, et al.
The Journal of Sexual Medicine|February 2, 2010
Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitorJames W Shaw, Gregory Reardon, David W Sandor, et al.
Bioorganic & Medicinal Chemistry|November 6, 2007
Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptorBrian E Kane, Marianne K O Grant, Esam E El-Fakahany, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8Peter Larson, Tamara A Kucaba, Zhengming Xiong, et al.
Journal of Medicinal Chemistry|March 17, 2006
Identification of compounds with anti-West Nile Virus activityJohn R Goodell, Francesc Puig-Basagoiti, Brett M Forshey, et al.
Nanoscale|November 8, 2018
Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapyHyunjoon Kim, Drishti Sehgal, Tamara A Kucaba, et al.
ACS Medicinal Chemistry Letters|July 28, 2012
Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine InductionCe Shi, Zhengming Xiong, Padmaja Chittepu, et al.
Bioorganic & Medicinal Chemistry|February 5, 2010
Synthesis and cancer cell cytotoxicity of substituted xanthenesRajan Giri, John R Goodell, Chenguo Xing, et al.
Pageof 5